Imatinib
10mM in DMSO
- Product Code: 198949
CAS:
152459-95-5
| Molecular Weight: | 493.62 g./mol | Molecular Formula: | C₂₉H₃₁N₇O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD05662257 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used primarily in the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) with Philadelphia chromosome, it works by inhibiting abnormal tyrosine kinase enzymes that drive uncontrolled cancer cell growth. Also effective in treating gastrointestinal stromal tumors (GIST) by targeting c-KIT and PDGFR kinase activity. Its targeted mechanism reduces damage to normal cells, making it a cornerstone of precision medicine in oncology. Administered orally, it has significantly improved survival rates in patients with these cancers.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿6,560.00 |
+
-
|
Imatinib
Used primarily in the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) with Philadelphia chromosome, it works by inhibiting abnormal tyrosine kinase enzymes that drive uncontrolled cancer cell growth. Also effective in treating gastrointestinal stromal tumors (GIST) by targeting c-KIT and PDGFR kinase activity. Its targeted mechanism reduces damage to normal cells, making it a cornerstone of precision medicine in oncology. Administered orally, it has significantly improved survival rates in patients with these cancers.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :